Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

According to data provided by World Health Organization, hepatocellular carcinoma (HCC) is the sixth most common cause of deaths due to cancer worldwide. Tremendous progress has been achieved over the last 10 years developing novel agents for HCC treatment, including small-molecule kinase inhibitors...

Descrición completa

Detalles Bibliográficos

Principais autores:	Monica A. Kamal, Yasmine M. Mandour, Mostafa K. Abd El-Aziz, Ulrike Stein, Hend M. El Tayebi
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-08-01
Series:	Molecules
Assuntos:	small molecule inhibitors growth factor receptors inhibitors tyrosine kinase inhibitors hepatocellular carcinoma molecular targets small molecules as immunomodulators
Acceso en liña:	https://www.mdpi.com/1420-3049/27/17/5537
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!